Issued Patents All Time
Showing 26–50 of 87 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11894109 | Production and delivery tracking and sample verification of patient-specific therapeutics | Nicholas J. Witchey | 2024-02-06 |
| 11857620 | Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus | Patrick Soon-Shiong, Peter Sieling, Shahrooz Rabizadeh, Lise Geissert, Annie Shin +4 more | 2024-01-02 |
| 11814436 | Anti-CD30 monoclonal antibodies and chimeric antigen receptors | Clifford Anders Olson, Helty Adisetiyo, Hermes J. Garban, Mark Guido, Heather McFarlane +2 more | 2023-11-14 |
| 11786577 | HIV treatment compositions and methods | Jeffrey Safrit, John H. Lee | 2023-10-17 |
| 11779637 | Targeted neoepitope vectors and methods therefor | — | 2023-10-10 |
| 11773158 | Method of treatment of a tumor with an IL-8 antibody | Patrick Soon-Shiong, Shiho Tanaka, Jon Thomas Van Lew, Clifford Anders Olson, Philip T. Liu | 2023-10-03 |
| 11773187 | Enhanced immunogenicity for GPI-anchored antigens | Wael Tadros, Annie Shin | 2023-10-03 |
| 11756651 | Method of treating a tumor in a patient based on an immune gene expression | Kevin B. Givechian, Kamil Wnuk, Chad Garner, Stephen Charles Benz, Hermes J. Garban +2 more | 2023-09-12 |
| 11753467 | Anti-TIM3 monoclonal antibodies and chimeric antigen receptors | Clifford Anders Olson, Hermes J. Garban, Raymond S. Wong, Shiho Tanaka | 2023-09-12 |
| 11725186 | Recombinant NK cells expressing co-stimulatory molecules | Patrick Soon-Shiong, Shahrooz Rabizadeh | 2023-08-15 |
| 11717564 | Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor | Stephen Charles Benz, Patrick Soon-Shiong, Andrew Nguyen | 2023-08-08 |
| 11684668 | Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s glycoprotein and modified N protein comprising an endosomal targeting sequence | — | 2023-06-27 |
| 11626187 | Systems, compositions, and methods for discovery of MSI and neoepitopes that predict sensitivity to checkpoint inhibitors | Andrew Nguyen, Patrick Soon-Shiong, Stephen Charles Benz, Shahrooz Rabizadeh | 2023-04-11 |
| 11623001 | Compositions and methods for viral cancer neoepitopes | Patrick Soon-Shiong, Stephen Charles Benz, Andrew Nguyen, Shahrooz Rabizadeh, Oleksandr Buzko +1 more | 2023-04-11 |
| 11585805 | Methods of immunogenic modulation | Patrick Soon-Shiong, Shahrooz Rabizadeh | 2023-02-21 |
| 11573230 | Rapid verification of virus particle production for a personalized vaccine | Adrian Rice, Frank R. Jones | 2023-02-07 |
| 11485957 | Modified EC7 cells having low toxicity to viral production payloads | Wael Tadros, Annie Shin | 2022-11-01 |
| 11480572 | Live cell imaging systems and methods to validate triggering of immune response | Shahrooz Rabizadeh, Nicholas J. Witchey | 2022-10-25 |
| 11439697 | Nant cancer vaccine | Patrick Soon-Shiong, Shahrooz Rabizadeh, Hans G. Klingemann, Laurent H. Boissel, Barry J. Simon | 2022-09-13 |
| 11441160 | Compositions and methods for viral delivery of neoepitopes and uses thereof | Patrick Soon-Shiong, Shahrooz Rabizadeh | 2022-09-13 |
| 11421016 | Cancer neoepitopes | Andrew Nguyen, Patrick Soon-Shiong, Shahrooz Rabizadeh, Stephen Charles Benz | 2022-08-23 |
| 11364265 | Recombinant erIL-15 NK cells | Patrick Soon-Shiong, Shahrooz Rabizadeh, Hans G. Klingemann | 2022-06-21 |
| 11361841 | High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies | Andrew Nguyen, John Zachary Sanborn, Stephen Charles Benz, Shahrooz Rabizadeh, Patrick Soon-Shiong +1 more | 2022-06-14 |
| 11311603 | HIV treatment compositions and methods | Jeffrey Safrit, John H. Lee | 2022-04-26 |
| 11298414 | Cellular adjuvants for viral infection | Raymond S. Wong, Peter Sieling, Philip T. Liu | 2022-04-12 |